1. Introduction {#sec1-marinedrugs-14-00218}
===============

Gorgonian corals belonging to the genus *Pinnigorgia* (Family Gorgoniidae), have proven to be rich sources of bioactive sterols \[[@B1-marinedrugs-14-00218],[@B2-marinedrugs-14-00218],[@B3-marinedrugs-14-00218],[@B4-marinedrugs-14-00218]\]. Previous bioassay results of these sterol analogues have demonstrated cytotoxic and anti-inflammatory activities. Following the above investigations, with the aim of discovering bioactive substances for new drug development in the future, we continue here to carry out an investigation on a Taiwan gorgonian *Pinnigorgia* sp., and two novel 9,11-secosterols, pinnigorgiols D (**1**) and E (**2**), with a rare carbon skeleton arrangement, were discovered ([Figure 1](#marinedrugs-14-00218-f001){ref-type="fig"}). The ability of these two compounds to inhibit the generation of superoxide anions and the release of elastase in *N*-formyl methionyl leucylphenylalanine/cytochalasin B (fMLP/CB)-induced neutrophils were also evaluated.

2. Results and Discussion {#sec2-marinedrugs-14-00218}
=========================

Pinnigorgiol D (**1**) was obtained as an oil and had the molecular formula C~30~H~46~O~6~ as determined by high-resolution electrospray ionization mass spectrum (HRESIMS) at *m*/*z* 525.31883 (calcd. for C~30~H~46~O~6~ + Na, 525.31866), requiring eight degrees of unsaturation. The IR absorptions of **1** showed the presence of hydroxy (ν~max~ 3446 cm^−1^), ester (ν~max~ 1739 cm^−1^), and ketonic carbonyl (ν~max~ 1717 cm^−1^) groups. The ^13^C NMR and distortionless enhancement of polarization transfer (DEPT) data of **1** ([Table 1](#marinedrugs-14-00218-t001){ref-type="table"}) indicated the presence of 30 carbons, including seven methyls, seven sp^3^ methylenes, eight sp^3^ methines, a disubstituted double bond, and six quaternary carbons. The ^1^H NMR spectrum ([Table 1](#marinedrugs-14-00218-t001){ref-type="table"}) exhibited seven methyl signals at δ~H~ 2.06 (3H, s, acetate methyl), 1.12 (3H, s), 1.04 (3H, d, *J* = 7.2 Hz), 0.91 (3H, d, *J* = 6.8 Hz), 0.90 (3H, s), 0.83 (3H, d, *J* = 6.8 Hz), and 0.81 (3H, d, *J* = 6.8 Hz). The signal at δ~H~ 4.54 (1H, ddd, *J* = 11.6, 11.6, 4.4 Hz) and 3.86 (1H, ddd, *J* = 11.6, 11.6, 6.0 Hz) were assumed to be an oxymethylene group. It was found that the NMR signals of **1** were similar to those of a known 9,11-secosterol analogue, pinnigorgiol A (**3**) ([Figure 1](#marinedrugs-14-00218-f001){ref-type="fig"}) \[[@B1-marinedrugs-14-00218]\], except that the signals corresponding to the 11-hydroxy group in **3** were replaced by signals for an acetoxy group in **1** ([Table 2](#marinedrugs-14-00218-t002){ref-type="table"}). The correlations from a nuclear Overhauser effect spectroscopy (NOESY) experiment of **1** also revealed that the stereochemistry of this metabolite was identical to that of **3**. Thus, pinnigorgiol D (**1**) was found to be the 11-*O*-acetyl derivative of **3**.

Pinnigorgiol E (**2**) was obtained as an oil and had the molecular formula C~30~H~48~O~6~ as determined by HRESIMS at *m/z* 527.33444 (calcd. for C~30~H~48~O~6~ + Na, 527.33431) and by analysis of NMR spectral data, requiring seven degrees of unsaturation. Initial analyses of the ^1^H and ^13^C NMR spectral data of **2** illustrated features very similar to those of **1** ([Table 1](#marinedrugs-14-00218-t001){ref-type="table"}) and a known secosterol, pinnigorgiol B (**4**) ([Figure 1](#marinedrugs-14-00218-f001){ref-type="fig"}) \[[@B1-marinedrugs-14-00218]\], except that the signals corresponding to the 11-hydroxy group in **4** were replaced by signals for an acetoxy group in **2** ([Table 3](#marinedrugs-14-00218-t003){ref-type="table"}). Based on the above observations, pinnigorgiol E (**2**) was assigned as the 11-*O*-acetyl derivative of pinnigorgiol B (**4**).

The CD spectra of pinnigoriols D (**1**), E (**2**), A (**3**), and B (**4**) in methanol displayed positive Cotton effects at 216 nm (Δε = +4.0), 214 nm (Δε = +4.6), 216 nm (Δε = +4.6), and 218 nm (Δε = +2.7), respectively, \[[@B1-marinedrugs-14-00218]\] ([Figure 2](#marinedrugs-14-00218-f002){ref-type="fig"}). These highlights confirmed that secosterols **1**--**4** possess the same configurations.

The hepatic stellate cell is the major cell type involved in liver fibrosis, which is the formation of scar tissue in response to liver damage. Secosterols **1** and **2** were tested against the HSC-T6 rat hepatic stellate cell line. Compounds **1** and **2** decreased the viability of HSC-T6 cells to 31.9% and 51.7%, respectively, at a concentration of 10 μM ([Figure 3](#marinedrugs-14-00218-f003){ref-type="fig"}).

In a previous study, pinnigorgiols A (**3**) and B (**4**) were reported to significantly decrease the cell viability of HSC-T6 cells to 13.0% and 20.8%, respectively, at a concentration of 10 μM ([Table 4](#marinedrugs-14-00218-t004){ref-type="table"}) \[[@B1-marinedrugs-14-00218]\]. It seemed that the C-11 hydroxy group and the double bond between C-22/23 are critical for the cytotoxic activity of secosterols **1**--**4**.

The in vitro anti-inflammatory effects of secosterols **1** and **2** were tested. Pinnigorgiols D (**1**) and E (**2**) were found to exhibit inhibitory effects on the generation of superoxide anions (IC~50~ = 3.5 and 3.9 μM, respectively) and the release of elastase (IC~50~ = 2.1 and 1.6 μM, respectively) by human neutrophils ([Table 5](#marinedrugs-14-00218-t005){ref-type="table"}). Pinnigorgiols A (**3**) and B (**4**) were also found to display inhibitory effects on the generation of superoxide anions (IC~50~ = 4.0 and 2.5 μM, respectively) and the release of elastase (IC~50~ = 5.3 and 3.1 μM, respectively) \[[@B1-marinedrugs-14-00218]\]. Secosterol **2** show stronger activity in the inhibitory effect on the release of elastase, which indicated that an acetoxy substituent at C-11 and the absence of C-22/23 double bond would enhance the activity by comparison with the structure and anti-inflammatory data of **2** with those of **1**, **3**, and **4**.

3. Experimental Section {#sec3-marinedrugs-14-00218}
=======================

3.1. General Experimental Procedures {#sec3dot1-marinedrugs-14-00218}
------------------------------------

Optical rotations were measured on a Jasco P-1010 digital polarimeter (Japan Spectroscopic Corporation, Tokyo, Japan). CD spectra were recorded on a Jasco J-810 circular dichroism spectropolarimeter (Japan Spectroscopic Corporation, Tokyo, Japan). Infrared spectra were recorded on a Jasco FT/IR-4100 spectrometer (Japan Spectroscopic Corporation, Tokyo, Japan); peaks are reported in cm^−1^. The NMR spectra were recorded on a Varian Mercury Plus 400 spectrometer, using the residual CHCl~3~ signal (δ~H~ 7.26 ppm) as an internal standard for ^1^H NMR and CDCl~3~ (δ~C~ 77.1 ppm) for ^13^C NMR; coupling constants (J) are given in Hz. ESIMS and HRESIMS were recorded using a Bruker 7 Tesla solariX FTMS system (Bruker, Bremen, Germany). Column chromatography was performed on silica gel (230--400 mesh, Merck, Darmstadt, Germany). TLC was carried out on precoated Kieselgel 60 F~254~ (0.25 mm, Merck, Darmstade, Germany); spots were visualized by spraying with 10% H~2~SO~4~ solution followed by heating. Normal-phase HPLC (NP-HPLC) was performed using a system comprised of a Hitachi L-7110 pump (Hitachi Ltd., Tokyo, Japan) and a Rheodyne 7725 injection port (Rheodyne LLC, Rohnert Park, CA, USA). A semi-preparative normal-phase column (Supelco Ascentis Si Cat \#:581515-U, 25 cm × 21.2 mm, 5 μm, Sigma-Aldrich, St. Louis, MO, USA) was used for NP-HPLC. Reversed-phase HPLC (RP-HPLC) was performed using a system comprised of a Hitachi L-2130 pump (Hitachi Ltd., Tokyo, Japan), a Hitachi L-2455 photodiode array detector (Hitachi Ltd., Tokyo, Japan), and a Rheodyne 7725 injection port (Rheodyne LLC., Rohnert Park, CA, USA). A reverse phase column (Luna^®^ 5 μm C18(2) 100 Å, AXIA Packed, 25 cm × 21.2 mm, Phenomenex Inc., Torrance, CA, USA) was used for RP-HPLC.

3.2. Animal Material {#sec3dot2-marinedrugs-14-00218}
--------------------

Specimens of the gorgonian corals *Pinnigorgia* sp. were collected by hand via scuba off the coast of Green Island, Taiwan, in August 2012 and stored in a freezer until extraction. A voucher specimen (NMMBA-TW-GC-2012-130) was deposited in the National Museum of Marine Biology & Aquarium, Taiwan. This organism was identified by a comparison with previous descriptions \[[@B5-marinedrugs-14-00218]\].

3.3. Extraction and Separation {#sec3dot3-marinedrugs-14-00218}
------------------------------

Sliced bodies of *Pinnigorgia* sp. (wet weight 1.98 kg; dry weight 0.86 kg) were extracted with ethyl acetate (EtOAc) at room temperature. The EtOAc extract (84.9 g) was partitioned between methanol (MeOH) and *n*-hexane. The MeOH layer (12.6 g) was separated on Sephadex LH-20 and eluted using a mixture of dichloromethane (DCM) and MeOH (1:1) to yield 7 subfractions A--F. Fraction F was separated by silica gel column chromatography and eluted using *n*-hexane/acetone (stepwise, 1:1--pure acetone) to afford eight subfractions F1--F8. Fraction F2 was purified by silica gel column chromatography and eluted using *n*-hexane/acetone (stepwise, 9:1--pure acetone) to yield 13 subfractions F2A--F2M. Fraction F2D was purified by NP-HPLC using a mixture of *n*-hexane/EtOAc (3:1) to yield 17 subfractions F2D1--F2D17. Fraction F2D15 was purified by RP-HPLC, using a mixture of MeOH/H~2~O (95:5) to yield **1** (6.5 mg) and **2** (8.7 mg), respectively.

Pinnigorgiol D (**1**): colorless oil; $\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{25}$ −6 (*c* 0.44, CHCl~3~); IR (neat) ν~max~ 3446, 1739, 1717 cm^−1^; ^1^H and ^13^C NMR data, see [Table 1](#marinedrugs-14-00218-t001){ref-type="table"}; ESIMS *m*/*z* 525 \[M + Na\]^+^; HRESIMS *m*/*z* 525.31883 (calcd. for C~30~H~46~O~6~ + Na, 525.31866).

Pinnigorgiol E (**2**): colorless oil; $\left\lbrack \mathsf{\alpha} \right\rbrack_{D}^{25}$ −4 (*c* 0.33, CHCl~3~); IR (neat) ν~max~ 3446, 1734, 1717 cm^−1^; ^1^H and ^13^C NMR data, see [Table 1](#marinedrugs-14-00218-t001){ref-type="table"}; ESIMS *m*/*z* 527 \[M + Na\]^+^; HRESIMS *m*/*z* 527.33444 (calcd. for C~30~H~48~O~6~ + Na, 527.33431).

3.4. Anti-Hepatofibric Assay {#sec3dot4-marinedrugs-14-00218}
----------------------------

The anti-hepatofibric effects of tested secosterols **1** and **2** were assayed using a WST-1 assay method. Anti-hepatofibric assays were carried out according to procedures described previously \[[@B6-marinedrugs-14-00218]\].

3.5. Generation of Superoxide Anions and Release of Elastase by Human Neutrophils {#sec3dot5-marinedrugs-14-00218}
---------------------------------------------------------------------------------

Human neutrophils were obtained by means of dextran sedimentation and Ficoll centrifugation. Measurements of superoxide anion generation and elastase release were carried out according to previously described procedures \[[@B7-marinedrugs-14-00218],[@B8-marinedrugs-14-00218]\]. Briefly, superoxide anion production was assayed by monitoring the superoxide dismutase-inhibitable reduction of ferricytochrome *c*. Elastase release experiments were performed using MeO--Suc--Ala--Ala--Pro--Valp--nitroanilide as the elastase substrate.

4. Conclusions {#sec4-marinedrugs-14-00218}
==============

Pinnigorgiols D (**1**) and E (**2**) are rare sterols containing a tricyclo\[5,2,1,1\]decane ring in their structures. Prior to this study, only four compounds of this type had been isolated from sea hare *Aplysia kurodai* \[[@B9-marinedrugs-14-00218]\] and gorgonian coral *Pinnigorgia* sp. \[[@B1-marinedrugs-14-00218]\]. In an anti-inflammatory activity test, secosterol **2** displayed significantly inhibitory effects on the release of elastase by human neutrophils and may become lead compounds in future marine anti-inflammatory drug development \[[@B10-marinedrugs-14-00218],[@B11-marinedrugs-14-00218]\]. The gorgonian coral *Pinnigorgia* sp. will be transplanted to culturing tanks located in the National Museum of Marine Biology & Aquarium, Taiwan, for the extraction of additional natural products to establish a stable supply of bioactive material.
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![Gorgonian coral *Pinnigorgia* sp. and the structures of pinnigorgiols D (**1**), E (**2**), A (**3**), and B (**4**).](marinedrugs-14-00218-g001){#marinedrugs-14-00218-f001}

![CD spectra of pinnigorgiols D (**1**), E (**2**), A (**3**), and B (**4**) \[[@B1-marinedrugs-14-00218]\].](marinedrugs-14-00218-g002){#marinedrugs-14-00218-f002}

![Secosterols **1** and **2** decreased viability of HSC-T6 in 10 μM for 24 h. Cells were treated with DMSO (control) and coral crude extract in 6 μg/mL. Cytotoxicity assay was monitored spectrophotometrically at 450 nm. Quantitative data are expressed as the mean ± S.E.M. (*n* = 3--4). \*\* *p* \< 0.01, \*\*\* *p* \< 0.001 compared to basal.](marinedrugs-14-00218-g003){#marinedrugs-14-00218-f003}

marinedrugs-14-00218-t001_Table 1

###### 

^1^H (400 MHz, CDCl~3~) and ^13^C (100 MHz, CDCl~3~) NMR data for secosterols **1** and **2**.

  Position   1                                    2                                                  
  ---------- ------------------------------------ ------------- ------------------------------------ -------------
  1          1.38 m; 1.25 m                       26.5, CH~2~   1.38 m; 1.25 m                       26.6, CH~2~
  2          2.02 m; 1.59 m                       23.8, CH~2~   2.03 m; 1.59 m                       24.1, CH~2~
  3          4.65 br s                            70.2, CH      4.65 dd (6.0, 5.2)                   70.2, CH
  4          2.91 dd (16.4, 6.8); 2.39 d (16.4)   44.1, CH~2~   2.91 dd (16.4, 6.8); 2.39 d (16.4)   44.0, CH~2~
  5                                               101.4, C                                           101.4, C
  6                                               207.7, C                                           207.7, C
  7          3.04 s                               59.6, CH      3.05 s                               59.9, CH
  8          3.18 dd (10.0, 2.0)                  48.2, CH      3.19 dd (10.0, 2.0)                  48.0, CH
  9                                               216.6, C                                           216.6, C
  10                                              49.4, C                                            49.5, C
  11         4.54 ddd (11.6, 11.6, 4.4)           61.2, CH~2~   4.52 ddd (11.6, 11.6, 4.8)           61.3, CH~2~
             3.86 ddd (11.6, 11.6, 6.0)                         3.87 ddd (11.6, 11.6, 6.0)           
  12         1.89 m; 1.67 m                       36.1, CH~2~   1.89 m; 1.61 m                       36.1, CH~2~
  13                                              46.7, C                                            46.8, C
  14         2.04 m                               45.8, CH      2.04 m                               46.1, CH
  15         1.94 m; 1.77 m                       27.3, CH~2~   1.92 m; 1.80 m                       27.0, CH~2~
  16         1.98 m; 1.45 m                       24.0, CH~2~   2.02 m; 1.42 m                       24.2, CH~2~
  17         1.43 m                               50.0, CH      1.42 m                               49.8, CH
  18         0.90 s                               17.0, CH~3~   0.90 s                               16.8, CH~3~
  19         1.12 s                               12.1, CH~3~   1.12 s                               12.1, CH~3~
  20         2.27 m                               36.8, CH      1.45 m                               33.3, CH
  21         1.04 d (7.2)                         22.6, CH~3~   1.04 d (7.2)                         20.4, CH~3~
  22         5.26 dd (15.6, 7.6)                  133.7, CH     1.45 m; 0.90 m                       32.6, CH~2~
  23         5.23 dd (15.6, 7.6)                  133.3, CH     1.37 m; 0.90 m                       31.8, CH~2~
  24         1.89 m                               43.1, CH      1.21 m                               39.0, CH
  25         1.48 m                               33.1, CH      1.56 m                               31.5, CH
  26         0.83 d (6.8)                         20.0, CH~3~   0.78 d (6.8)                         17.6, CH~3~
  27         0.81 d (6.8)                         19.7, CH~3~   0.85 d (6.8)                         20.4, CH~3~
  28         0.91 d (6.8)                         17.5, CH~3~   0.77 d (6.8)                         15.5, CH~3~
  11-OAc                                          172.5, C                                           172.4, C
             2.06 s                               21.2, CH~3~   2.05 s                               21.2, CH~3~

marinedrugs-14-00218-t002_Table 2

###### 

NMR data for the 11-acetoxy component in pinnigorgiol D (**1**), and the 11-hydroxy component in pinnigorgiol A (**3**).

  Position   1                            3 ^a^                                       
  ---------- ---------------------------- ------------- ----------------------------- -------------
  11         4.54 ddd (11.6, 11.6, 4.4)   61.2, CH~2~   3.83 m                        59.0, CH~2~
             3.86 ddd (11.6, 11.6, 6.0)                                               
  12         1.89 m; 1.67 m               36.1, CH~2~   1.89 dt (15.5, 5.5); 1.74 m   39.5, CH~2~
  13                                      46.7, C                                     46.6, C
  11-OAc                                  172.5, C                                    
             2.06 s                       21.2, CH~3~                                 

^a^ Data was reported by Chang et al. \[[@B1-marinedrugs-14-00218]\].

marinedrugs-14-00218-t003_Table 3

###### 

NMR data for the 11-acetoxy component in pinnigorgiol E (**2**), and the 11-hydroxy component in pinnigorgiol B (**4**).

  Position   2                            4 ^a^                                             
  ---------- ---------------------------- ------------- ----------------------------------- -------------
  11         4.52 ddd (11.6, 11.6, 4.8)   61.3, CH~2~   3.81 m                              59.1, CH~2~
             3.87 ddd (11.6, 11.6, 6.0)                                                     
  12         1.89 m; 1.61 m               36.1, CH~2~   1.89 ddd (16.0, 6.0, 5.2); 1.69 m   39.7, CH~2~
  13                                      46.8, C                                           46.6, C
  11-OAc                                  172.4, C                                          
             2.05 s                       21.2, CH~3~                                       

^a^ Data was reported by Chang et al. \[[@B1-marinedrugs-14-00218]\].

marinedrugs-14-00218-t004_Table 4

###### 

Secosterols **1**--**4** decreased viability of HSC-T6 in 10 μM for 24 h.

  Compound                       1      2      3 ^a^   4 ^a^
  ------------------------------ ------ ------ ------- -------
  Inhibition rate (% of basal)   31.9   51.7   13.0    20.8

^a^ Data was reported by Chang et al. \[[@B1-marinedrugs-14-00218]\].

marinedrugs-14-00218-t005_Table 5

###### 

Inhibitory effects of secosterols **1**--**4** on the generation of superoxide anions and the release of elastase by human neutrophils in response to fMet-Leu-Phe/cytochalastin B (fMLP/CB).

  Compound    Superoxide Anion   Elastase Release
  ----------- ------------------ ------------------
  **1**       3.5                2.1
  **2**       3.9                1.6
  **3** ^a^   4.0                5.3
  **4** ^a^   2.5                3.1

^a^ Data was reported by Chang et al. \[[@B1-marinedrugs-14-00218]\].
